Autor: "Quinn, N." - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: A critique of the second consensus criteria for multiple system atrophy.
Autorzy :: Stankovic I; Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Quinn N; University College London, Institute of Neurology, Queen Square, London, UK.
Vignatelli L; Istituto di Ricovero e Cura a Carattere Scientifico, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Antonini A; Department of Neuroscience, University of Padua, Padua, Italy.
Berg D; Department of Neurology, Christian Albrecht University, Kiel, Germany.; Hertie Institute for Clinical Brain Research Tübingen, Tübingen, Germany.
Coon E; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Cortelli P; Istituto di Ricovero e Cura a Carattere Scientifico, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Dipartimento Scienze Biomediche e Neuromotorie, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Fanciulli A; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Ferreira JJ; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Freeman R; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Halliday G; Brain and Mind Centre, Sydney Medical School, University of Sydney, Camperdown, Australia; School of Medical Sciences, University of New South Wales, Wales, Kensington, Australia; and Neuroscience Research Australia, Randwick, Australia.
Höglinger GU; Department of Neurology, Technische Universität München, and German Center for Neurodegenerative Diseases, München, Germany.
Iodice V; Autonomic Unit, National Hospital for Neurology and Neurosurgery, Queen Square/Division of Clinical Neurology, Institute of Neurology, University College London, London, UK.
Kaufmann H; Dysautonomia Center, Langone Medical Center, New York University School of Medicine, New York, New York, USA.
Klockgether T; Department of Neurology, University of Bonn, and German Center for Neurodegenerative Diseases, Bonn, Germany.
Kostic V; Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.
Krismer F; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Lang A; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
Levin J; Department of Neurology, Ludwig-Maximilians-Universität München, and German Center for Neurodegenerative Diseases, München, Germany.
Low P; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Mathias C; Autonomic and Neurovascular Medicine Centre, Hospital of St John & St Elizabeth, London, UK.; Lindo Wing, Imperial College Healthcare National Health Service Trust, St Mary's Hospital, London, UK.; Queen Square Institute of Neurology, University College London, London, UK.
Meissner WG; French Reference Center for MSA, Department of Neurology, University Hospital Bordeaux, Bordeaux, France.; Institute of Neurodegenerative Disorders, University Bordeaux, Bordeaux, France.
Kaufmann LN; Dysautonomia Center, Langone Medical Center, New York University School of Medicine, New York, New York, USA.
Palma JA; Dysautonomia Center, Langone Medical Center, New York University School of Medicine, New York, New York, USA.
Panicker JN; University College London, Institute of Neurology, Queen Square, London, UK.; Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Pellecchia MT; Center for Neurodegenerative Diseases, Department of Medicine and Surgery, Neuroscience Section, University of Salerno, Fisciano, Italy.
Sakakibara R; Neurology, Internal Medicine, Sakura Medical Center, Toho University, Sakura, Japan.
Schmahmann J; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Scholz SW; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, Maryland, USA.
Singer W; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Stamelou M; HYGEIA Hospital, Athens, Greece, Neurology Clinic, University Marburg, Marburg, Germany.; Department of Neurology, University of Athens, Athens, Greece.
Tolosa E; Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain.
Tsuji S; Department of Molecular Neurology, The University of Tokyo, Graduate School of Medicine, Tokyo, Japan.; International University of Health and Welfare, Chiba, Japan.
Seppi K; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Poewe W; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Wenning GK; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.; Pokaż więcej
Corporate Authors :: Movement Disorder Society Multiple System Atrophy Study Group
Źródło :: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2019 Jul; Vol. 34 (7), pp. 975-984. Date of Electronic Publication: 2019 Apr 29.
Typ publikacji :: Journal Article
MeSH Terms :: Consensus*
Genetic Predisposition to Disease*
Multiple System Atrophy*/diagnosis
Multiple System Atrophy*/drug therapy
Multiple System Atrophy*/genetics
Levodopa/*therapeutic use
Humans ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates.
Autorzy :: Kuoppamäki M; Neurodegenerative Diseases Research Centre, King's College, London, U.K. />Al-Barghouthy G
Jackson MJ
Smith LA
Quinn N
Jenner P; Pokaż więcej
Źródło :: Journal of neural transmission (Vienna, Austria : 1996) [J Neural Transm (Vienna)] 2007 Sep; Vol. 114 (9), pp. 1147-53. Date of Electronic Publication: 2007 Apr 20.
Typ publikacji :: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Dyskinesia, Drug-Induced/*physiopathology
Levodopa/*administration & dosage
MPTP Poisoning/*physiopathology
Animals ; Callithrix ; Dose-Response Relationship, Drug ; Female ; Levodopa/toxicity ; Male ; Motor Activity/drug effects ; Motor Activity/physiology ; Severity of Illness Index
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
Autorzy :: Stacy M; Duke University Medical Center, 932 Morreene Road, Durham, NC 27705, USA. />Bowron A
Guttman M
Hauser R
Hughes K
Larsen JP
LeWitt P
Oertel W
Quinn N
Sethi K
Stocchi F; Pokaż więcej
Źródło :: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2005 Jun; Vol. 20 (6), pp. 726-33.
Typ publikacji :: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Surveys and Questionnaires*
Levodopa/*adverse effects
Motor Activity/*drug effects
Parkinson Disease/*physiopathology
Activities of Daily Living ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Case-Control Studies ; Cognition/drug effects ; Cognition/physiology ; Cognition Disorders/etiology ; Disability Evaluation ; Female ; Humans ; Levodopa/therapeutic use ; Male ; Middle Aged ; Motor Activity/physiology ; Movement Disorders/etiology ; Outcome Assessment, Health Care ; Parkinson Disease/drug therapy ; Retrospective Studies ; Severity of Illness Index
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Levodopa in the treatment of Parkinson's disease: current controversies.
Autorzy :: Olanow CW; Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. />Agid Y
Mizuno Y
Albanese A
Bonuccelli U
Damier P
De Yebenes J
Gershanik O
Guttman M
Grandas F
Hallett M
Hornykiewicz O
Jenner P
Katzenschlager R
Langston WJ
LeWitt P
Melamed E
Mena MA
Michel PP
Mytilineou C
Obeso JA
Poewe W
Quinn N
Raisman-Vozari R
Rajput AH
Rascol O
Sampaio C
Stocchi F; Pokaż więcej
Źródło :: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2004 Sep; Vol. 19 (9), pp. 997-1005.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Antiparkinson Agents/*adverse effects
Levodopa/*adverse effects
Parkinson Disease/*drug therapy
Antiparkinson Agents/pharmacokinetics ; Antiparkinson Agents/therapeutic use ; Corpus Striatum/drug effects ; Corpus Striatum/metabolism ; Dyskinesia, Drug-Induced/etiology ; Humans ; Levodopa/pharmacokinetics ; Levodopa/therapeutic use ; Receptors, Dopamine/drug effects ; Receptors, Dopamine/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.
Autorzy :: Kuoppamäki M; Neurodegenerative Diseases Research Centre, King's College, London, United Kingdom.
Al-Barghouthy G
Jackson M
Smith L
Zeng BY
Quinn N
Jenner P; Pokaż więcej
Źródło :: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2002 Nov; Vol. 17 (6), pp. 1312-7.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Dyskinesia, Drug-Induced/*physiopathology
Levodopa/*toxicity
Parkinsonian Disorders/*physiopathology
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine ; Animals ; Callithrix ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Female ; Male ; Motor Activity/drug effects ; Motor Skills/drug effects ; Neurologic Examination/drug effects ; Parkinsonian Disorders/chemically induced ; Recurrence
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Levodopa reversible loss of the Piper frequency oscillation component in Parkinson's disease.
Autorzy :: McAuley JH; MRC Human Movement and Balance Unit, Institute of Neurology, 23 Queen Square, London WC1N 3BG, UK. />Corcos DM
Rothwell JC
Quinn NP
Marsden CD; Pokaż więcej
Źródło :: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2001 Apr; Vol. 70 (4), pp. 471-6.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Fingers/*physiopathology
Levodopa/*therapeutic use
Muscle Contraction/*drug effects
Muscle Contraction/*physiology
Muscles/*physiopathology
Parkinson Disease/*drug therapy
Parkinson Disease/*physiopathology
Electromyography ; Humans ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.
Autorzy :: Schrag A; Department of Clinical Neurology, Institute of Neurology, London, UK.
Quinn N; Pokaż więcej
Źródło :: Brain : a journal of neurology [Brain] 2000 Nov; Vol. 123 ( Pt 11), pp. 2297-305.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Dyskinesia, Drug-Induced/*epidemiology
Levodopa/*adverse effects
Parkinson Disease/*complications
Parkinson Disease/*drug therapy
Age of Onset ; Aged ; Disease Progression ; Dopamine Agonists/adverse effects ; Dyskinesia, Drug-Induced/physiopathology ; Humans ; Outpatients ; Parkinson Disease/epidemiology ; Prevalence ; Quality of Life ; Regression Analysis ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Parkinson's disease: drug therapy.
Autorzy :: Oertel WH; Philipps-Universität Marburg, Klinik für Neurologie, Zentrum für Nervenheilkunde, Germany.
Quinn NP; Pokaż więcej
Źródło :: Bailliere's clinical neurology [Baillieres Clin Neurol] 1997 Apr; Vol. 6 (1), pp. 89-108.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antiparkinson Agents/*therapeutic use
Dopamine Agonists/*therapeutic use
Levodopa/*therapeutic use
Parkinson Disease/*drug therapy
Amantadine/therapeutic use ; Antiparkinson Agents/adverse effects ; Apomorphine/therapeutic use ; Cholinergic Antagonists/therapeutic use ; Dyskinesia, Drug-Induced/etiology ; Guidelines as Topic ; Humans ; Levodopa/adverse effects ; Monoamine Oxidase Inhibitors/therapeutic use ; Selegiline/therapeutic use ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Clinical drug monitoring by microdialysis: application to levodopa therapy in Parkinson's disease.
Autorzy :: O'Connell MT; Pharmacology and Therapeutics Unit, National Hospital for Neurology and Neurosurgery, London, UK.
Tison F
Quinn NP
Patsalos PN; Pokaż więcej
Źródło :: British journal of clinical pharmacology [Br J Clin Pharmacol] 1996 Dec; Vol. 42 (6), pp. 765-9.
Typ publikacji :: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Antiparkinson Agents/*pharmacokinetics
Antiparkinson Agents/*therapeutic use
Levodopa/*pharmacokinetics
Levodopa/*therapeutic use
Microdialysis/*methods
Parkinson Disease/*drug therapy
Parkinson Disease/*metabolism
Antiparkinson Agents/analysis ; Area Under Curve ; Drug Monitoring ; Half-Life ; Humans ; Levodopa/analysis ; Microdialysis/adverse effects ; Tyrosine/analogs & derivatives ; Tyrosine/analysis ; Tyrosine/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease.
Autorzy :: Wenning GK; University Department of Clinical Neurology, Institute of Neurology, London, England.
O'Connell MT
Patsalos PN
Quinn NP; Pokaż więcej
Źródło :: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 1995 Sep; Vol. 10 (5), pp. 664-7.
Typ publikacji :: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Antitubercular Agents/*pharmacokinetics
Isoniazid/*pharmacokinetics
Levodopa/*metabolism
Levodopa/*therapeutic use
Parkinson Disease/*drug therapy
Rifampin/*pharmacokinetics
Tuberculosis, Pulmonary/*complications
3,4-Dihydroxyphenylacetic Acid/metabolism ; Antitubercular Agents/therapeutic use ; Dopa Decarboxylase/metabolism ; Homovanillic Acid/metabolism ; Humans ; Isoniazid/therapeutic use ; Levodopa/blood ; Male ; Middle Aged ; Parkinson Disease/complications ; Rifampin/therapeutic use ; Tuberculosis, Pulmonary/drug therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study.
Autorzy :: Stocchi F; Department of Neuroscience, University of Rome La Sapienza, Italy.
Quinn NP
Barbato L
Patsalos PN
O'Connel MT
Ruggieri S
Marsden CD; Pokaż więcej
Źródło :: Clinical neuropharmacology [Clin Neuropharmacol] 1994 Feb; Vol. 17 (1), pp. 38-44.
Typ publikacji :: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Levodopa/*analogs & derivatives
Parkinson Disease/*drug therapy
Aged ; Chromatography, High Pressure Liquid ; Delayed-Action Preparations ; Female ; Humans ; Levodopa/administration & dosage ; Levodopa/pharmacokinetics ; Levodopa/therapeutic use ; Male ; Middle Aged ; Parkinson Disease/blood
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease.
Autorzy :: Steiger MJ; Department of Clinical Neurology, Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, U.K.
Stocchi F
Bramante L
Ruggieri S
Quinn NP; Pokaż więcej
Źródło :: Clinical neuropharmacology [Clin Neuropharmacol] 1992 Dec; Vol. 15 (6), pp. 501-4.
Typ publikacji :: Journal Article
MeSH Terms :: Benserazide/*therapeutic use
Carbidopa/*therapeutic use
Levodopa/*analogs & derivatives
Parkinson Disease/*drug therapy
Benserazide/administration & dosage ; Carbidopa/administration & dosage ; Drug Combinations ; Humans ; Levodopa/administration & dosage ; Levodopa/therapeutic use ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Levodopa challenge test in Parkinson's disease.
Autorzy :: Steiger MJ
Quinn NP; Pokaż więcej
Źródło :: Lancet (London, England) [Lancet] 1992 Mar 21; Vol. 339 (8795), pp. 751-2.
Typ publikacji :: Comparative Study; Letter
MeSH Terms :: Levodopa*/therapeutic use
Parkinson Disease/*drug therapy
Apomorphine ; Humans ; Parkinson Disease/physiopathology ; Parkinson Disease, Secondary/drug therapy ; Parkinson Disease, Secondary/physiopathology
: Raport

Szczegóły Pełny tekst

Skocz do pozycji: 18 18.

Tytuł :: Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.
Autorzy :: Stocchi F; 1st Clinic of Neurology, Department of Neurological Science, University La Sapienza, Rome, Italy.
Ruggieri S
Carta A
Ryatt J
Quinn N
Jenner P
Marsden CD
Agnoli A; Pokaż więcej
Źródło :: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 1992; Vol. 7 (3), pp. 249-56.
Typ publikacji :: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Levodopa/*administration & dosage
Levodopa/*analogs & derivatives
Neurologic Examination/*drug effects
Parkinson Disease/*drug therapy
Aged ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Infusions, Intravenous ; Levodopa/adverse effects ; Levodopa/pharmacokinetics ; Male ; Middle Aged ; Motor Skills/drug effects ; Parkinson Disease/blood
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Dopa-responsive dystonia.
Autorzy :: Quinn NP; Pokaż więcej
Źródło :: Developmental medicine and child neurology [Dev Med Child Neurol] 1991 Aug; Vol. 33 (8), pp. 750.
Typ publikacji :: Comment; Letter
MeSH Terms :: Dystonia/*drug therapy
Levodopa/*therapeutic use
Spastic Paraplegia, Hereditary/*drug therapy
Child ; Dystonia/genetics ; Genes, Dominant/genetics ; Humans ; Spastic Paraplegia, Hereditary/genetics
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.
Autorzy :: Steiger MJ; Department of Clinical Neurology, Institute of Neurology, London, U.K.
Stocchi F
Carta A
Ruggieri S
Agnoli A
Quinn NP
Marsden CD; Pokaż więcej
Źródło :: Clinical neuropharmacology [Clin Neuropharmacol] 1991 Jun; Vol. 14 (3), pp. 241-4.
Typ publikacji :: Journal Article
MeSH Terms :: Benserazide/*administration & dosage
Levodopa/*administration & dosage
Levodopa/*analogs & derivatives
Parkinson Disease/*drug therapy
Administration, Oral ; Aged ; Benserazide/therapeutic use ; Drug Combinations ; Humans ; Levodopa/therapeutic use ; Middle Aged
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Quinn, N."" wg kryterium: Autor

Aktywne filtry:

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język